Introducing the NEW Demeditec AMH ELISA

Products are for professional/laboratory use only.  We are pleased to announce the launch of the new Demeditec AMH ELISA.

Clinical Application:

AMH (Anti-Mullerian Hormone) is the ideal marker in reproductive medicine, as it gives information on ovarian reserve. It becomes particularly relevant in family planning, unfulfilled desire for children, sterility therapy or and menopause onset.

Furthermore, AMH contributes in the diagnosis of certain diseases such as granulosa cell tumors or polycystic ovary syndrome (PCOS).

Advantages of AMH ELISA:

• Short Assay Time
• Short Hands-on Time
• Components Ready-to-use
• Standards Calibrated against 1st WHO International Reference Reagent, Mullerian Inhibiting Substance/Anti-Mullerian Hormone, NIBSC code:16/190
• Two controls included
• Good Correlation to the Gold Standard Method
• Good Assay Performance (Validated according to CLSI Guidelines)
• Labelled for IVD use

Differences of Demeditec AMH ELISA to others:  

• No pre-dilution of samples

• Reagents ready to use (except Wash Solution)
• No shaker or incubator needed
• Assay procedure straight forward
• Shortest assay time compared to competition!
• Very good sensitivity and precision
• No cross-reactivity to relevant substances

Assay Details:

Enzyme immunoassay for the quantitative measurement of Anti-Müllerian Hormone (AMH) in serum or plasma.

This ELISA is based on the sandwich principle.

Demeditec can confirm that the antibodies used in their two assays do not infringe the Beckman Coulter patents as their antibodies do not bind to the patented region of AMH.

Method Comparison to Roche Reference Tests:

Go Back